مكتبة

Item request has been placed!

Item request cannot be made.

Processing Request

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Diagnosis and consequences of gastropharyngeal reflux.

Authors : Smit, C.F.¹; Mathus-Vliegen, L.M.H.²; Devriese, P.P.³

Source: Clinical Otolaryngology & Allied Sciences. Dec2000, Vol. 25 Issue 6, p440-455. 16p. 5 Charts, 1 Graph.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

The control of gastric acid and Helicobacter pylori eradication.

Authors : Sachs, G.¹ (AUTHOR); Shin, J. M.¹ (AUTHOR); Munson, K.¹ (AUTHOR)

Source: Alimentary Pharmacology & Therapeutics. Nov2000, Vol. 14 Issue 11, p1383-1401. 19p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Proton pump inhibitors: better acid suppression when taken before a meal than without a meal.

Authors : Hatlebakk, J. G.¹ (AUTHOR); Katz, P. O.¹ (AUTHOR); Camacho‐Lobato, L.¹ (AUTHOR)

Source: Alimentary Pharmacology & Therapeutics. Oct2000, Vol. 14 Issue 10, p1267-1272. 6p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

ASSESSMENT OF GASTRIC EMPTYING IN THE MOUSE USING THE [13C]-OCTANOIC ACID BREATH TEST.

Authors : Symonds, Erin L.; Butler, Ross N.; Omari, Taher I.

Source: Clinical & Experimental Pharmacology & Physiology. Sep2000, Vol. 27 Issue 9, p671. 5p. 2 Diagrams, 1 Chart, 4 Graphs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Helicobacter pylori infection influences nocturnal gastric acid breakthrough.

Authors : Katsube, T.¹ (AUTHOR); Adachi, K.¹ (AUTHOR); Kawamura, A.¹ (AUTHOR)

Source: Alimentary Pharmacology & Therapeutics. Aug2000, Vol. 14 Issue 8, p1049-1056. 8p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Review article: the clinical influence of Helicobacter pylori in effective acid suppression—implications for the treatment of gastro-oesophageal reflux disease.

Authors : Martínek, J.¹ (AUTHOR); Kužela, L.² (AUTHOR); Špičák, J.¹ (AUTHOR)

Source: Alimentary Pharmacology & Therapeutics. Aug2000, Vol. 14 Issue 8, p979-990. 12p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Pharmacodynamics and kinetics of omeprazole MUPS 20 mg and pantoprazole 40 mg during repeated oral administration in Helicobacter pylori-negative subjects.

Authors : Geus, W. P.^1,2 (AUTHOR); Mathôt, R. A. A.³ (AUTHOR); Mulder, P. G. H.⁴ (AUTHOR)

Source: Alimentary Pharmacology & Therapeutics. Aug2000, Vol. 14 Issue 8, p1057-1064. 8p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazole.

Authors : Katz¹ (AUTHOR); Hatlebakk¹ (AUTHOR); Castell¹ (AUTHOR)

Source: Alimentary Pharmacology & Therapeutics. Jun2000, Vol. 14 Issue 6, p709-714. 6p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Rabeprazole produces rapid, potent, and long-acting inhibition of gastric acid secretion in subjects with Helicobacter pylori infection.

Authors : Ohning¹ (AUTHOR); Barbuti¹ (AUTHOR); Kovacs¹ (AUTHOR)

Source: Alimentary Pharmacology & Therapeutics. Jun2000, Vol. 14 Issue 6, p701-708. 8p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

A placebo-controlled study to assess the effects of 7-day dosing with 10, 20 and 40 mg rabeprazole on 24-h intragastric acidity and plasma gastrin in healthy male subjects.

Authors : Williams¹ (AUTHOR); Blanshard¹ (AUTHOR); Millson¹ (AUTHOR)

Source: Alimentary Pharmacology & Therapeutics. Jun2000, Vol. 14 Issue 6, p691-699. 9p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Diagnosis and consequences of gastropharyngeal reflux.

The control of gastric acid and Helicobacter pylori eradication.

Proton pump inhibitors: better acid suppression when taken before a meal than without a meal.

ASSESSMENT OF GASTRIC EMPTYING IN THE MOUSE USING THE [13C]-OCTANOIC ACID BREATH TEST.

Helicobacter pylori infection influences nocturnal gastric acid breakthrough.

Review article: the clinical influence of Helicobacter pylori in effective acid suppression—implications for the treatment of gastro-oesophageal reflux disease.

Pharmacodynamics and kinetics of omeprazole MUPS 20 mg and pantoprazole 40 mg during repeated oral administration in Helicobacter pylori-negative subjects.

Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazole.

Rabeprazole produces rapid, potent, and long-acting inhibition of gastric acid secretion in subjects with Helicobacter pylori infection.

A placebo-controlled study to assess the effects of 7-day dosing with 10, 20 and 40 mg rabeprazole on 24-h intragastric acidity and plasma gastrin in healthy male subjects.